According to Nykode Therapeutics's latest financial reports the company has HK$0.89 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$0.89 B | -29.17% |
2023-12-31 | HK$1.26 B | -21.35% |
2022-12-31 | HK$1.60 B | -9.51% |
2021-12-31 | HK$1.77 B | 10.05% |
2020-12-31 | HK$1.61 B | 5686.64% |
2019-12-31 | HK$27.9 M | 86.86% |
2018-12-31 | HK$14.93 M | -37.59% |
2017-12-31 | HK$23.93 M |